Evidence map›Paper›PMID 40696185›Full record

ArticleNature2025

Author Correction: Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer.

Gabe S Sonke, Annemiek van Ommen-Nijhof, Noor Wortelboer, Vincent van der Noort, Astrid C P Swinkels, Hedwig M Blommestein, Cristina Guerrero Paez, Linda Mol, Aart Beeker, Karin Beelen and 13 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Gabe S SonkeDepartment of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. g.sonke@nki.nl.ORCID http://orcid.org/0000-0001-8088-9628
Annemiek van Ommen-Nijhof *Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-1797-1060
Noor Wortelboer *Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.ORCID http://orcid.org/0009-0006-1649-748X
Vincent van der NoortDepartment of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Astrid C P SwinkelsClinical Research Department, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-0047-0948
Hedwig M BlommesteinErasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-5846-0531
Cristina Guerrero PaezDutch Breast Cancer Society, Utrecht, The Netherlands.
Linda MolClinical Research Department, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
Aart BeekerDepartment of Medical Oncology, Spaarne Gasthuis, Hoofddorp, The Netherlands.
Karin BeelenDepartment of Medical Oncology, Rijnstate Hospital, Arnhem, The Netherlands.
Lisanne C HammingDepartment of Medical Oncology, Medical Center Leeuwarden, Leeuwarden, The Netherlands.
Joan B HeijnsDepartment of Medical Oncology, Amphia, Breda, The Netherlands.
Aafke H HonkoopDepartment of Medical Oncology, Isala Clinics, Zwolle, The Netherlands.ORCID http://orcid.org/0000-0002-8066-2164
Paul C de JongDepartment of Medical Oncology, St Antonius Hospital, Nieuwegein, The Netherlands.
Quirine C van Rossum-SchornagelDepartment of Medical Oncology, Franciscus Gasthuis & Vlietland, Schiedam, The Netherlands.
Christa van Schaik-van de MheenDepartment of Medical Oncology, Meander Medical Center, Amersfoort, The Netherlands.
Jolien TolDepartment of Medical Oncology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
Cathrien S Tromp-van DrielDepartment of Medical Oncology, Gelre Hospital, Apeldoorn, The Netherlands.
Suzan VrijaldenhovenDepartment of Medical Oncology, Northwest Hospital Group, Alkmaar, The Netherlands.
A Elise van Leeuwen-StokDutch Breast Cancer Research Group, BOOG Study Center, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-1988-4099
Inge R KoningsDepartment of Medical Oncology, Amsterdam University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Agnes JagerDepartment of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-7713-1450
SONIA Study Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40696185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.